Physician preferences for extra-glycemic effects of type 2 diabetes treatments.

ABSTRACT:

Introduction

The purpose of this study was to quantify United States (US) and United Kingdom (UK) physicians' preferences for attributes of type 2 diabetes treatments.

Methods

Samples of general practitioners (GPs) and endocrinologists in the US (n = 204) and the UK (n = 200) completed a discrete-choice experiment in which respondents chose between pairs of hypothetical type 2 diabetes treatments in a series of trade-off questions. The questions described hypothetical injectable treatments with differing levels of attributes, such as glucose control and treatment side effects. Relative importance of attributes was estimated by a multivariate regression model for limited dependent variables. These results were used to calculate how the predicted probability of choosing hypoth

SUBMITTER: Poulos C 

PROVIDER: S-EPMC3889326 | biostudies-literature | 2013 Dec

REPOSITORIES: biostudies-literature